RAPT Therapeutics SG&A Expense (Quarterly) Insights

RAPT Therapeutics Inc (RAPT)

4.03 -0.11 (-2.66%) USD | NASDAQ | May 17, 16:00

4.03 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	7.737M
December 31, 2023	6.453M
September 30, 2023	6.897M
June 30, 2023	6.722M
March 31, 2023	5.988M
December 31, 2022	4.977M
September 30, 2022	5.079M
June 30, 2022	5.436M
March 31, 2022	4.748M
December 31, 2021	4.491M
September 30, 2021	3.774M
June 30, 2021	3.76M
March 31, 2021	4.012M

Date	Value
December 31, 2020	3.483M
September 30, 2020	3.197M
June 30, 2020	2.802M
March 31, 2020	3.289M
December 31, 2019	2.625M
September 30, 2019	1.733M
June 30, 2019	2.692M
March 31, 2019	1.674M
December 31, 2018	1.291M
September 30, 2018	1.364M
June 30, 2018	1.468M
March 31, 2018	1.057M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.733M

Minimum

Sep 2019

7.737M

Maximum

Mar 2024

4.495M

Average

4.252M

Median

SG&A Expense (Quarterly) Benchmarks